A microcarrier is a support matrix allowing for the growth of adherent cells in bioreactors.
Due to the COVID-19 pandemic, the global Microcarrier market size is estimated to be worth US$ 1033 million in 2021 and is forecast to a readjusted size of US$ 1340.2 million by 2028 with a CAGR of 3.3% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Microcarrier market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Microcarrier landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
In 2017, Europe dominated the global microcarriers market. Growth in this market can mainly be attributed to factors such as the increasing incidence of cancer, growing number of venture capital investments, availability of technologically advanced products, and strategic expansion of biopharmaceutical companies in this region. However, the RoW is expected to register the highest CAGR in the forecast period.
This report focuses on Microcarrier volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Microcarrier market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Microcarrier Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Cationic Microcarriers
Collagen-coated Microcarriers
Protein-coated Microcarriers
Untreated Microcarriers
Other Microcarriers
Segment by Application
Vaccine Manufacturing
Cell Therapy
Other Applications
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Thermo Fisher
GE Healthcare
Corning
Sartorius
Danaher
Merck
Becton, Dickinson
Eppendorf
Hi-Media Laboratories
Lonza Group